e-ESO Podcasts

143 Episoade

1. Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature review

   Publicat: 02.02.2023
2. Basics of prostate cancer pathology

   Publicat: 26.01.2023
3. Oligometastaic breast cancer

   Publicat: 19.01.2023
4. Artificial intelligence for prediction of treatment outcomes in breast cancer: Systematic review of design, reporting standards, and bias

   Publicat: 12.01.2023
5. Summary/Review - Reporting Guidelines - CHEERS

   Publicat: 06.12.2022
6. Role of immunotherapy in head and neck cancer

   Publicat: 01.12.2022
7. AYAs with cancer: the right to be forgotten

   Publicat: 24.11.2022
8. Summary/Review - Reporting Guidelines - SQUIRE

   Publicat: 17.11.2022
9. Male breast cancer

   Publicat: 10.11.2022
10. Summary/Review - Reporting Guidelines - SRQR

    Publicat: 03.11.2022
11. Summary/Review - Reporting Guidelines - AGREE

    Publicat: 27.10.2022
12. Breast Cancer: Frequently Asked Questions and Answers

    Publicat: 20.10.2022
13. The role of Medical Physicist in Oncology

    Publicat: 13.10.2022
14. How to approach to breast cancer patient who had not received neoadjuvant chemo and staged T2NO postoperatively?

    Publicat: 06.10.2022
15. Parp inhibitors in ovarian cancer

    Publicat: 29.09.2022
16. Primary endocrine resistant in recurrent locoregional only Breast cancer (role of endocrine therapy)

    Publicat: 22.09.2022
17. Should Prostate Cancer Patients With History of Cardiovascular Events Be Preferentially Treated With Luteinizing Hormone-Releasing Hormone Antagonists?

    Publicat: 15.09.2022
18. The use of Lutetium PSMA as treatment in mCRPC – in what sequence and how to best select patients

    Publicat: 08.09.2022
19. Use of Medical Cannabis in Oncology. Knowledges and attitudes among oncologist and patient.

    Publicat: 01.09.2022
20. Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?

    Publicat: 27.07.2022